Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
paper
Cited
Public
Unavailable
- Authors
- Yeager, Meredith; Orr, Nick; Hayes, Richard B; Jacobs, Kevin B; Kraft, Peter; Wacholder, Sholom; Minichiello, Mark J; Fearnhead, Paul; Yu, Kai; Chatterjee, Nilanjan; Wang, Zhaoming; Welch, Robert; Staats, Brian J; Calle, Eugenia E; Feigelson, Heather Spencer; Thun, Michael J; Rodriguez, Carmen; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R; Giovannucci, Edward; Willett, Walter C; Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L; Gelmann, Edward P; Tucker, Margaret; Gerhard, Daniela S; Fraumeni, Joseph F; Hoover, Robert; Hunter, David J; Chanock, Stephen J; Thomas, Gilles
- Year
- 2007
- Journal
- Nature genetics
- PMID
- 17401363
- DOI
- 10.1038/ng2022
Recently, common variants on human chromosome 8q24 were found to be associated with prostate cancer risk. While conducting a genome-wide association study in the Cancer Genetic Markers of Susceptibility project with 550,000 SNPs in a nested case-control study (1,172 cases and 1,157 controls of European origin), we identified a new association at 8q24 with an independent effect on prostate cancer susceptibility. The most significant signal is 70 kb centromeric to the previously reported SNP, rs1447295, but shows little evidence of linkage disequilibrium with it. A combined analysis with four additional studies (total: 4,296 cases and 4,299 controls) confirms association with prostate cancer for rs6983267 in the centromeric locus (P = 9.42 x 10(-13); heterozygote odds ratio (OR): 1.26, 95% confidence interval (c.i.): 1.13-1.41; homozygote OR: 1.58, 95% c.i.: 1.40-1.78). Each SNP remained significant in a joint analysis after adjusting for the other (rs1447295 P = 1.41 x 10(-11); rs6983267 P = 6.62 x 10(-10)). These observations, combined with compelling evidence for a recombination hotspot between the two markers, indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry. We estimate that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked by rs1447295 (21% versus 9%).
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Molecular targeted therapies, omics, and AI based theranostics approaches for the treatment of prostate cancer. | Khan S et al. | β | 2026 | β |
| Comprehensive dissection of cis-regulatory elements in a 2.8βMb topologically associated domain in six human cancers. | Caragine CM et al. | β | 2025 | β |
| Decoding the germline genetic architecture of prostate cancer at a single cell resolution. | Wang C et al. | β | 2025 | β |
| Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study. | Ji C et al. | β | 2025 | β |
| Genetic variations related to the prostate cancer risk: A field synopsis and revaluation by Bayesian approaches of genome-wide association studies. | Monteiro AVO et al. | β | 2025 | β |
| Introduction to androgenetics: terminology, approaches, and impactful studies across 60 years. | Akbari A et al. | β | 2025 | β |
| Shared requirement for MYC upstream super-enhancer region in tissue regeneration and cancer. | Sur I et al. | β | 2025 | β |
| From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine. | Ren S et al. | β | 2024 | β |
| Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated <i>FAM227A</i> expression. | Fan L et al. | β | 2024 | β |
| Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease. | Heydari R et al. | β | 2024 | β |
| Understanding the Biological Basis of Polygenic Risk Scores and Disparities in Prostate Cancer: A Comprehensive Genomic Analysis. | Zhang W et al. | β | 2024 | β |
| Cross-cancer pleiotropic analysis identifies three novel genetic risk loci for colorectal cancer. | Sun J et al. | β | 2023 | β |
| Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives. | Foo JC et al. | β | 2023 | β |
| Genome-wide association testing in malaria studies in the presence of overdominance. | Akoth M et al. | β | 2023 | β |
| Long-range gene regulation in hormone-dependent cancer. | Tettey TT et al. | β | 2023 | β |
| Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis. | Sato G et al. | β | 2023 | β |
| Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis. | Wu Y et al. | β | 2023 | β |
| Variations in genomic regions encoding long non-coding RNA genes associated with increased prostate cancer risk. | Bozgeyik E | β | 2023 | β |
| A microRNA Transcriptome-wide Association Study of Prostate Cancer Risk. | Larson NB et al. | β | 2022 | β |
| Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men. | Silva-Ramirez B et al. | β | 2022 | β |
| Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer. | Zhu Q et al. | β | 2022 | β |
| Associations of genetic susceptibility to 16 cancers with risk of breast cancer overall and by intrinsic subtypes. | Choi J et al. | β | 2022 | β |
| Deciphering the Polygenic Basis of Racial Disparities in Prostate Cancer By an Integrative Analysis of Genomic and Transcriptomic Data. | Zhang W et al. | β | 2022 | β |
| Exploring the effects of genetic variation on gene regulation in cancer in the context of 3D genome structure. | Osman N et al. | β | 2022 | β |
| Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients. | Wefel JS et al. | β | 2022 | β |
| Genetic variant located on chromosome 17p12 contributes to prostate cancer onset and biochemical recurrence. | Pavel AG et al. | β | 2022 | β |
| Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. | Xu J et al. | β | 2022 | β |
| Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc. | Peng Y et al. | β | 2022 | β |
| Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution. | Sodir NM et al. | β | 2022 | β |
| Review of prostate cancer genomic studies in Africa. | Samtal C et al. | β | 2022 | β |
| The role of single-nucleotide polymorphisms of the 8q24 chromosome region in patients with concomitant bladder and prostate cancer. | Gakis G et al. | β | 2022 | β |
| TNFRSF13B is a potential contributor to prostate cancer. | Li CY et al. | β | 2022 | β |
| African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. | Karunamuni RA et al. | β | 2021 | β |
| A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort. | Lin X et al. | β | 2021 | β |
| Alternative polyadenylation: An untapped source for prostate cancer biomarkers and therapeutic targets? | Kurozumi A et al. | β | 2021 | β |
| Common Susceptibility Loci for Male Breast Cancer. | Maguire S et al. | β | 2021 | β |
| Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis. | Zhang W et al. | β | 2021 | β |
| Does Subtelomeric Position of COMMD5 Influence Cancer Progression? | Campion CG et al. | β | 2021 | β |
| Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification. | Olsen M et al. | β | 2021 | β |
| Genetic ancestry differences in pediatric asthma readmission are mediated by socioenvironmental factors. | Mersha TB et al. | β | 2021 | β |
| Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer. | Cheng Y et al. | β | 2021 | β |
| Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease. | Saunders EJ et al. | β | 2021 | β |
| Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population. | Karimi F et al. | β | 2021 | β |
| LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 Polymorphisms on 8q24 Associated with Lung Cancer. | Yu WL et al. | β | 2021 | β |
| MicroRNA-1205 Regulation of FRYL in Prostate Cancer. | Naidoo M et al. | β | 2021 | β |
| Prostate cancer: Therapeutic prospect with herbal medicine. | Ghosh S et al. | β | 2021 | β |
| 8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer. | Dupont WD et al. | β | 2020 | β |
| A duplex probe-directed recombinase amplification assay for detection of single nucleotide polymorphisms on 8q24 associated with prostate cancer. | Duan Q et al. | β | 2020 | β |
| Association of germline genetic variants with <i>TMPRSS2-ERG</i> fusion status in prostate cancer. | Kohaar I et al. | β | 2020 | β |
| Association of Hypomorphic P2X7 Receptor Genotype With Age. | Sanz JM et al. | β | 2020 | β |
| Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population. | Beikzadeh B et al. | β | 2020 | β |
| Cumulative evidence of relationships between multiple variants in 8q24 region and cancer incidence. | Tong Y et al. | β | 2020 | β |
| Disparities in prostate cancer incidence and mortality rates: Solvable or not? | Badal S et al. | β | 2020 | β |
| DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. | Dai JY et al. | β | 2020 | β |
| Genetic Analysis Reveals a Significant Contribution of <i>CES1</i> to Prostate Cancer Progression in Taiwanese Men. | Ke CC et al. | β | 2020 | β |
| Identification and characterization of functional long noncoding RNAs in cancer. | Olivero CE et al. | β | 2020 | β |
| <i>MYC</i> DNA Methylation in Prostate Tumor Tissue Is Associated with Gleason Score. | Barry KH et al. | β | 2020 | β |
| LDtrait: An Online Tool for Identifying Published Phenotype Associations in Linkage Disequilibrium. | Lin SH et al. | β | 2020 | β |
| Long non-coding RNA CASC8 polymorphisms are associated with the risk of esophageal cancer in a Chinese population. | Sang Y et al. | β | 2020 | β |
| Multi-ethnic transcriptome-wide association study of prostate cancer. | Fiorica PN et al. | β | 2020 | β |
| Psychosocial Stress, Glucocorticoid Signaling, and Prostate Cancer Health Disparities in African American Men. | Woods-Burnham L et al. | β | 2020 | β |
| Significance of Single-Nucleotide Variants in Long Intergenic Non-protein Coding RNAs. | Zou H et al. | β | 2020 | β |
| Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer. | Montazeri Z et al. | β | 2020 | β |
| The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine. | Lewis DD et al. | β | 2020 | β |
| The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis. | Crumbaker M et al. | β | 2020 | β |
| The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert. | Gu Y et al. | β | 2020 | β |
| Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer. | Zhang W et al. | β | 2020 | β |
| Validation of a prostate cancer polygenic risk score. | Black MH et al. | β | 2020 | β |
| Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics. | Suwinski P et al. | β | 2019 | β |
| An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set. | DeRycke MS et al. | β | 2019 | β |
| A simple approximation to the bias of gene-environment interactions in case-control studies with silent disease. | Lobach I et al. | β | 2019 | β |
| Association analyses identify 31 new risk loci for colorectal cancer susceptibility. | Law PJ et al. | β | 2019 | β |
| Association of lncRNA <i>CCAT2</i> and <i>CASC8</i> Gene Polymorphisms with Hepatocellular Carcinoma. | Wu ER et al. | β | 2019 | β |
| Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma. | Wang X et al. | β | 2019 | β |
| Concept and benchmarks for assessing narrow-sense validity of genetic risk score values. | Yu H et al. | β | 2019 | β |
| Developing Growth-Associated Molecular Markers Via High-Throughput Phenotyping in Spinach. | Awika HO et al. | β | 2019 | β |
| Discovering genetic interactions bridging pathways in genome-wide association studies. | Fang G et al. | β | 2019 | β |
| FAM84B promotes prostate tumorigenesis through a network alteration. | Jiang Y et al. | β | 2019 | β |
| Genetic polymorphisms in <i>Sox17</i> associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study. | Li M et al. | β | 2019 | β |
| MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer. | Wang Y et al. | β | 2019 | β |
| Novel Common Genetic Susceptibility Loci for Colorectal Cancer. | Schmit SL et al. | β | 2019 | β |
| Pivotal prognostic and diagnostic role of the long nonβcoding RNA colon cancerβassociated transcript 1 expression in human cancer (Review). | Wang N et al. | β | 2019 | β |
| Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts. | Shi Z et al. | β | 2019 | β |
| Admixture Mapping Links RACGAP1 Regulation to Prostate Cancer in African Americans. | Wilson BD et al. | β | 2018 | β |
| A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer. | Zhang X et al. | β | 2018 | β |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | Schumacher FR et al. | β | 2018 | β |
| Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis. | Benna C et al. | β | 2018 | β |
| Association study of genetic variation in the autophagy lysosome pathway genes and risk of eight kinds of cancers. | Tan J et al. | β | 2018 | β |
| Cancer genetics, precision prevention and a call to action. | Turnbull C et al. | β | 2018 | β |
| Characterization of Nine Cancer-Associated Variants in Human DNA Polymerase ΞΊ. | Antczak NM et al. | β | 2018 | β |
| Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia. | Hu J et al. | β | 2018 | β |
| Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery. | Hu Y et al. | β | 2018 | β |
| Cumulative Evidence for Relationships Between 8q24 Variants and Prostate Cancer. | Tong Y et al. | β | 2018 | β |
| DNArCdb: A database of cancer biomarkers in DNA repair genes that includes variants related to multiple cancer phenotypes. | Silvestrov P et al. | β | 2018 | β |
| Gene-environment interactions in case-control studies with silent disease. | Lobach I et al. | β | 2018 | β |
| Genetics and biology of prostate cancer. | Wang G et al. | β | 2018 | β |
| Genetic variants in the histone methylation and acetylation pathway and their risks in eight types of cancers. | Fu LN et al. | β | 2018 | β |
| Genome-Wide Association Studies in Glioma. | Kinnersley B et al. | β | 2018 | β |
| Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. | Quigley DA et al. | β | 2018 | β |
| Identification of Pleiotropic Cancer Susceptibility Variants from Genome-Wide Association Studies Reveals Functional Characteristics. | Wu YH et al. | β | 2018 | β |
| Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis. | Kim T et al. | β | 2018 | β |
| Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans. | Winter JM et al. | β | 2018 | β |
| Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood. | Rebbeck TR | β | 2018 | β |
| Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities. | Tan SH et al. | β | 2018 | β |
| Prostate Cancer Germline Variations and Implications for Screening and Treatment. | Dias A et al. | β | 2018 | β |
| Prostate cancer health disparities: An immuno-biological perspective. | Kumar S et al. | β | 2018 | β |
| Relationship between Parameters Linked to Surgery, Hospitalization and Single Nucleotide Polymorphism in Patients with Colorectal Cancer. | Chirca A et al. | β | 2018 | β |
| Single-cell whole-genome sequencing identifies human papillomavirus integration in cervical tumour cells prior to and following radiotherapy. | Yang D et al. | β | 2018 | β |
| Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival. | Freedman JA et al. | β | 2018 | β |
| Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing. | Viswanathan SR et al. | β | 2018 | β |
| The chromatin accessibility landscape of primary human cancers. | Corces MR et al. | β | 2018 | β |
| TheΒ molecular biology of prostate cancer: current understanding and clinical implications. | Gandhi J et al. | β | 2018 | β |
| The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer. | Lancho O et al. | β | 2018 | β |
| The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries. | Swerdlow AJ et al. | β | 2018 | β |
| The personal and clinical utility of polygenic risk scores. | Torkamani A et al. | β | 2018 | β |
| WITHDRAWN: Single nucleotide polymorphism, a putative driver for the role of long intergeneric non-coding RNA. | Zou H et al. | β | 2018 | β |
| ALKBH7 Variant Related to Prostate Cancer Exhibits Altered Substrate Binding. | Walker AR et al. | β | 2017 | β |
| A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness. | Lynch SM et al. | β | 2017 | β |
| Association between 8q24 Gene Polymorphisms and the Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. | Li R et al. | β | 2017 | β |
| Association between 8q24 rs6983267 polymorphism and cancer susceptibility: a meta-analysis involving 170,737 subjects. | Zhu M et al. | β | 2017 | β |
| Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery | Hu Y et al. | β | 2017 | β |
| Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer. | Chandrasekaran G et al. | β | 2017 | β |
| Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway. | Cornu JN et al. | β | 2017 | β |
| Genetic variants within the cancer susceptibility region 8q24 and ovarian cancer risk in Han Chinese women. | Han J et al. | β | 2017 | β |
| Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer. | Lee IS et al. | β | 2017 | β |
| Genome-wide association studies of cancer: current insights and future perspectives. | Sud A et al. | β | 2017 | β |
| Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. | Melin BS et al. | β | 2017 | β |
| Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study. | Sun X et al. | β | 2017 | β |
| Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. | Briollais L et al. | β | 2017 | β |
| Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications. | Castillo J et al. | β | 2017 | β |
| Lack of association of CASC8 rs1447295 with colorectal cancer in Iranian population: A multicenter case-control study. | Haerian MS et al. | β | 2017 | β |
| Long noncoding RNAs in gastric cancer carcinogenesis and metastasis. | Nasrollahzadeh-Khakiani M et al. | β | 2017 | β |
| Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer. | Winter JM et al. | β | 2017 | β |
| Mice deficient of <i>Myc</i> super-enhancer region reveal differential control mechanism between normal and pathological growth. | Dave K et al. | β | 2017 | β |
| Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci. | Larson NB et al. | β | 2017 | β |
| Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk. | Barry KH et al. | β | 2017 | β |
| Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. | Rebbeck TR | β | 2017 | β |
| Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial. | Chen H et al. | β | 2017 | β |
| Revealing allele-specific gene expression by single-cell transcriptomics. | Benitez JA et al. | β | 2017 | β |
| Structural variants caused by <i>Alu</i> insertions are associated with risks for many human diseases. | Payer LM et al. | β | 2017 | β |
| TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese. | Lin X et al. | β | 2017 | β |
| The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. | Sanchez-Martin M et al. | β | 2017 | β |
| To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer. | Shen P et al. | β | 2017 | β |
| Upregulation of FAM84B during prostate cancer progression. | Wong N et al. | β | 2017 | β |
| Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis. | Zhong X et al. | β | 2017 | β |
| Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer. | KobberΓΈ Lauridsen B et al. | β | 2017 | β |
| A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population. | Marzec J et al. | β | 2016 | β |
| An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer. | Bishop KS et al. | β | 2016 | β |
| An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk. | Wu Q et al. | β | 2016 | β |
| Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer. | Lange EM et al. | β | 2016 | β |
| Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes. | Penney KL et al. | β | 2016 | β |
| Chromatin interactions and candidate genes at ten prostate cancer risk loci. | Du M et al. | β | 2016 | β |
| Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity. | Hu L et al. | β | 2016 | β |
| Dynein axonemal heavy chain 8 promotes androgen receptor activity and associates with prostate cancer progression. | Wang Y et al. | β | 2016 | β |
| Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations. | Zhou S et al. | β | 2016 | β |
| Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases. | Murakawa Y et al. | β | 2016 | β |
| Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival. | Meshkat M et al. | β | 2016 | β |
| Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer. | Grampp S et al. | β | 2016 | β |
| Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. | Teerlink CC et al. | β | 2016 | β |
| Germline genetic profiling in prostate cancer: latest developments and potential clinical applications. | Ahmed M et al. | β | 2016 | β |
| Heritability of prostate cancer: a tale of rare variants and common single nucleotide polymorphisms. | Wu X et al. | β | 2016 | β |
| IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. | Oktay Y et al. | β | 2016 | β |
| Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population. | Cornu JN et al. | β | 2016 | β |
| MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery. | Kumar B et al. | β | 2016 | β |
| Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study. | Qu LS et al. | β | 2016 | β |
| Nonsyndromic cleft lip with or without cleft palate and cancer: Evaluation of a possible common genetic background through the analysis of GWAS data. | Dunkhase E et al. | β | 2016 | β |
| Origins of Bladder Cancer. | Czerniak B et al. | β | 2016 | β |
| Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers. | Ge Y et al. | β | 2016 | β |
| Replication study of 34 common SNPs associated with prostate cancer in the Romanian population. | Jinga V et al. | β | 2016 | β |
| The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research. | Kennedy AE et al. | β | 2016 | β |
| The contribution of rare variation to prostate cancer heritability. | Mancuso N et al. | β | 2016 | β |
| The Cumulative Effect of Gene-Gene and Gene-Environment Interactions on the Risk of Prostate Cancer in Chinese Men. | Liu M et al. | β | 2016 | β |
| The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource. | Zhu CS et al. | β | 2016 | β |
| The role of enhancers in cancer. | Sur I et al. | β | 2016 | β |
| Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease. | Orlando G et al. | β | 2016 | β |
| XPG Gene Polymorphisms and the Risk of Gastric Cardia Adenocarcinoma. | Zhou RM et al. | β | 2016 | β |
| A comparative study of disease genes and drug targets in the human protein interactome. | Sun J et al. | β | 2015 | β |
| A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. | Hoffmann TJ et al. | β | 2015 | β |
| A model to determine colorectal cancer risk using common genetic susceptibility loci. | Hsu L et al. | β | 2015 | β |
| An efficient weighted tag SNP-set analytical method in genome-wide association studies. | Yan B et al. | β | 2015 | β |
| A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. | Al-Tassan NA et al. | β | 2015 | β |
| An overview of SNP interactions in genome-wide association studies. | Li P et al. | β | 2015 | β |
| A Sequence Kernel Association Test for Dichotomous Traits in Family Samples under a Generalized Linear Mixed Model. | Yan Q et al. | β | 2015 | β |
| A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation. | Grill S et al. | β | 2015 | β |
| Associating Multivariate Quantitative Phenotypes with Genetic Variants in Family Samples with a Novel Kernel Machine Regression Method. | Yan Q et al. | β | 2015 | β |
| Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects. | Ao X et al. | β | 2015 | β |
| Association between PLCE1 rs2274223 A > G polymorphism and cancer risk: proof from a meta-analysis. | Xue W et al. | β | 2015 | β |
| Association of prostate cancer risk variants with gene expression in normal and tumor tissue. | Penney KL et al. | β | 2015 | β |
| Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects. | Li Q et al. | β | 2015 | β |
| Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. | Helfand BT et al. | β | 2015 | β |
| CCDC26 rs4295627 polymorphism and glioma risk: a meta-analysis. | Cui T | β | 2015 | β |
| Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. | GrΓΌnewald TG et al. | β | 2015 | β |
| Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach. | Mizrahi I et al. | β | 2015 | β |
| Comparative Transcriptomes and EVO-DEVO Studies Depending on Next Generation Sequencing. | Liu T et al. | β | 2015 | β |
| Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results. | Yao K et al. | β | 2015 | β |
| Deterministic identification of specific individuals from GWAS results. | Cai R et al. | β | 2015 | β |
| Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. | Zhang X et al. | β | 2015 | β |
| EPMA position paper in cancer: current overview and future perspectives. | Grech G et al. | β | 2015 | β |
| Fine-mapping additive and dominant SNP effects using group-LASSO and fractional resample model averaging. | Sabourin J et al. | β | 2015 | β |
| Genetic variants in the inositol phosphate metabolism pathway and risk of different types of cancer. | Tan J et al. | β | 2015 | β |
| Genome-wide association study identifies multiple susceptibility loci for glioma. | Kinnersley B et al. | β | 2015 | β |
| Genome-wide association study of colorectal cancer identifies six new susceptibility loci. | Schumacher FR et al. | β | 2015 | β |
| Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. | Betz RC et al. | β | 2015 | β |
| Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set. | Thibodeau SN et al. | β | 2015 | β |
| Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. | Qian DC et al. | β | 2015 | β |
| Junk DNA and the long non-coding RNA twist in cancer genetics. | Ling H et al. | β | 2015 | β |
| Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer. | Wang M et al. | β | 2015 | β |
| Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. | Cheng TH et al. | β | 2015 | β |
| Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment. | Gala MK et al. | β | 2015 | β |
| Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer. | Barry KH et al. | β | 2015 | β |
| Prostate cancer in East Asia: evolving trend over the last decade. | Zhu Y et al. | β | 2015 | β |
| Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome. | Du M et al. | β | 2015 | β |
| Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial. | Liss MA et al. | β | 2015 | β |
| PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer? | Ilboudo A et al. | β | 2015 | β |
| Quantifying the heritability of glioma using genome-wide complex trait analysis. | Kinnersley B et al. | β | 2015 | β |
| Rare-Variant Kernel Machine Test for Longitudinal Data from Population and Family Samples. | Yan Q et al. | β | 2015 | β |
| Regulation of MYC gene expression by aberrant Wnt/Ξ²-catenin signaling in colorectal cancer. | Rennoll S et al. | β | 2015 | β |
| Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci. | Chen H et al. | β | 2015 | β |
| The 8q24 rs6983267G variant is associated with increased thyroid cancer risk. | Sahasrabudhe R et al. | β | 2015 | β |
| The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma. | Chen X et al. | β | 2015 | β |
| The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer. | Hayashi H et al. | β | 2015 | β |
| Two susceptibility loci identified for prostate cancer aggressiveness. | Berndt SI et al. | β | 2015 | β |
| Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer. | Wu L et al. | β | 2015 | β |
| 8q24 risk alleles and prostate cancer in African-Barbadian men. | Cropp CD et al. | β | 2014 | β |
| Admixture mapping of prostate cancer in African Americans participating in the North Carolina-Louisiana Prostate Cancer Project (PCaP). | Bensen JT et al. | β | 2014 | β |
| A genome-wide association study of severe teenage acne in European Americans. | Zhang M et al. | β | 2014 | β |
| A method for detecting long non-coding RNAs with tiled RNA expression microarrays. | Lund SH et al. | β | 2014 | β |
| An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility. | Breyer JP et al. | β | 2014 | β |
| A prostate cancer model build by a novel SVM-ID3 hybrid feature selection method using both genotyping and phenotype data from dbGaP. | YΓΌcebaΕ SC et al. | β | 2014 | β |
| Architecture of inherited susceptibility to colorectal cancer: a voyage of discovery. | Whiffin N et al. | β | 2014 | β |
| A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians. | Oskina NA et al. | β | 2014 | β |
| Assessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer: statistical evaluation of epistasis. | Chen LS et al. | β | 2014 | β |
| Association of genetic and non-genetic risk factors with the development of prostate cancer in Malaysian men. | Munretnam K et al. | β | 2014 | β |
| Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis. | Zhu ML et al. | β | 2014 | β |
| A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes. | Williams KA et al. | β | 2014 | β |
| Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells. | Ghalali A et al. | β | 2014 | β |
| CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population. | Wei XB et al. | β | 2014 | β |
| C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. | He X et al. | β | 2014 | β |
| Comprehensive functional annotation of 77 prostate cancer risk loci. | Hazelett DJ et al. | β | 2014 | β |
| DNA methylation levels at chromosome 8q24 in peripheral blood are associated with 8q24 cancer susceptibility loci. | Barry KH et al. | β | 2014 | β |
| Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator? | Butoescu V et al. | β | 2014 | β |
| Efficient identification of context dependent subgroups of risk from genome-wide association studies. | Dyson G et al. | β | 2014 | β |
| Elevated levels of glycosylphosphatidylinositol (GPI) anchored proteins in plasma from human cancers detected by C. septicum alpha toxin. | Dolezal S et al. | β | 2014 | β |
| Estimating the heritability of colorectal cancer. | Jiao S et al. | β | 2014 | β |
| Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium. | Blein S et al. | β | 2014 | β |
| Functional annotation of putative regulatory elements at cancer susceptibility Loci. | Rosse SA et al. | β | 2014 | β |
| Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. | Kantor ED et al. | β | 2014 | β |
| Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers. | Li WQ et al. | β | 2014 | β |
| Genetic variation at 8q24, family history of cancer, and upper gastrointestinal cancers in a Chinese population. | Tarleton HP et al. | β | 2014 | β |
| Genetic variation: effect on prostate cancer. | Sissung TM et al. | β | 2014 | β |
| Genome-wide association scan for variants associated with early-onset prostate cancer. | Lange EM et al. | β | 2014 | β |
| Germline genetic variants associated with prostate cancer and potential relevance to clinical practice. | Goh CL et al. | β | 2014 | β |
| High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer. | Hsing AW et al. | β | 2014 | β |
| Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. | Whiffin N et al. | β | 2014 | β |
| Kernel-machine testing coupled with a rank-truncation method for genetic pathway analysis. | Yan Q et al. | β | 2014 | β |
| Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: a meta-analysis. | Liu G et al. | β | 2014 | β |
| Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. | Kim T et al. | β | 2014 | β |
| MicroRNA sequence polymorphisms and the risk of different types of cancer. | Hu Y et al. | β | 2014 | β |
| Most common 'sporadic' cancers have a significant germline genetic component. | Lu Y et al. | β | 2014 | β |
| MYC association with cancer risk and a new model of MYC-mediated repression. | Cole MD | β | 2014 | β |
| Nonparametric tests of associations with disease based on U-statistics. | Jin L et al. | β | 2014 | β |
| Nucleic acid-based tissue biomarkers of urologic malignancies. | Dietrich D et al. | β | 2014 | β |
| Pathway-guided identification of gene-gene interactions. | Wang X et al. | β | 2014 | β |
| Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. | Cheng I et al. | β | 2014 | β |
| Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population. | Cao DL et al. | β | 2014 | β |
| Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. | Weng PH et al. | β | 2014 | β |
| Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. | Shui IM et al. | β | 2014 | β |
| Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. | Kerns SL et al. | β | 2014 | β |
| The epidemiology and clinical implications of genetic variation in prostate cancer. | Helfand BT et al. | β | 2014 | β |
| The genetic epidemiology of prostate cancer and its clinical implications. | Eeles R et al. | β | 2014 | β |
| The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making. | Van den Broeck T et al. | β | 2014 | β |
| Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites. | Jiang J et al. | β | 2014 | β |
| Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. | Wang H et al. | β | 2014 | β |
| Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond. | Mikropoulos C et al. | β | 2014 | β |
| Variants at IRX4 as prostate cancer expression quantitative trait loci. | Xu X et al. | β | 2014 | β |
| 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy. | Fromont G et al. | β | 2013 | β |
| 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort. | Chan JY et al. | β | 2013 | β |
| A common variant at 8q24.21 is associated with renal cell cancer. | Gudmundsson J et al. | β | 2013 | β |
| A nonparametric regression method for multiple longitudinal phenotypes using multivariate adaptive splines. | Zhu W et al. | β | 2013 | β |
| A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. | Lin X et al. | β | 2013 | β |
| Assessment of possible association between rs3787016 and prostate cancer risk in Serbian population. | NikoliΔ ZZ et al. | β | 2013 | β |
| Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis. | Zhang H et al. | β | 2013 | β |
| Association of variants in estrogen-related pathway genes with prostate cancer risk. | Holt SK et al. | β | 2013 | β |
| Associations between single-nucleotide polymorphisms and epidural ropivacaine consumption in patients undergoing breast cancer surgery. | Liu J et al. | β | 2013 | β |
| Association testing strategy for data from dense marker panels. | Lee D et al. | β | 2013 | β |
| BAYESIAN SEMIPARAMETRIC ANALYSIS FOR TWO-PHASE STUDIES OF GENE-ENVIRONMENT INTERACTION. | Ahn J et al. | β | 2013 | β |
| Beliefs and attitudes towards participating in genetic research - a population based cross-sectional study. | Kerath SM et al. | β | 2013 | β |
| CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. | Redis RS et al. | β | 2013 | β |
| Characterization of germline copy number variation in high-risk African American families with prostate cancer. | Ledet EM et al. | β | 2013 | β |
| Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. | Agalliu I et al. | β | 2013 | β |
| Chronic chlorpyrifos exposure does not promote prostate cancer in prostate specific PTEN mutant mice. | Svensson RU et al. | β | 2013 | β |
| Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort. | Goh CL et al. | β | 2013 | β |
| Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. | Orozco G et al. | β | 2013 | β |
| Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. | Henrion M et al. | β | 2013 | β |
| Deciphering the 8q24.21 association for glioma. | Enciso-Mora V et al. | β | 2013 | β |
| Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence. | Alaiyan B et al. | β | 2013 | β |
| Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer. | Ziaei SA et al. | β | 2013 | β |
| Enhancing systems medicine beyond genotype data by dynamic patient signatures: having information and using it too. | Emmert-Streib F et al. | β | 2013 | β |
| Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men. | Na R et al. | β | 2013 | β |
| Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis. | Simpson CL et al. | β | 2013 | β |
| Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. | Bensen JT et al. | β | 2013 | β |
| Genetics and genomics of prostate cancer. | Dean M et al. | β | 2013 | β |
| Genome-wide association studies on prostate cancer: the end or the beginning? | Chen R et al. | β | 2013 | β |
| HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). | Xu J et al. | β | 2013 | β |
| Hypothesis driven single nucleotide polymorphism search (HyDn-SNP-S). | Swett RJ et al. | β | 2013 | β |
| Identification of a novel gene by whole human genome tiling array. | Ishida H et al. | β | 2013 | β |
| Identification of somatic mutations in human prostate cancer by RNA-Seq. | Xu X et al. | β | 2013 | β |
| Inherited susceptibility to CLL. | Speedy HE et al. | β | 2013 | β |
| Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. | Enciso-Mora V et al. | β | 2013 | β |
| Metabolomic signatures of aggressive prostate cancer. | McDunn JE et al. | β | 2013 | β |
| MicroRNAs in farm animals. | Wang X et al. | β | 2013 | β |
| Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes. | Ren S et al. | β | 2013 | β |
| Post genome-wide association studies functional characterization of prostate cancer risk loci. | Jiang J et al. | β | 2013 | β |
| Privacy-Preserving Data Exploration in Genome-Wide Association Studies. | Johnson A et al. | β | 2013 | β |
| Prostate cancer and osteoporosis. | Tuck SP et al. | β | 2013 | β |
| Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis. | Nakagawa H | β | 2013 | β |
| Prostate cancer risk-associated genetic markers and their potential clinical utility. | Xu J et al. | β | 2013 | β |
| Prostate cancer susceptibility genes on 8p21-23 in a Dutch population. | Zeegers MP et al. | β | 2013 | β |
| SNP-SNP interaction network in angiogenesis genes associated with prostate cancer aggressiveness. | Lin HY et al. | β | 2013 | β |
| TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects. | Wang HM et al. | β | 2013 | β |
| The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial. | Chen Z et al. | β | 2013 | β |
| The genetics of innate immunity sensors and human disease. | Pothlichet J et al. | β | 2013 | β |
| The genomic landscape of prostate cancer. | Spans L et al. | β | 2013 | β |
| The SLC22 family with transporters of organic cations, anions and zwitterions. | Koepsell H | β | 2013 | β |
| Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer. | Cornu JN et al. | β | 2013 | β |
| 8q24 risk alleles in West African and Caribbean men. | Murphy AB et al. | β | 2012 | β |
| A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk. | Newcombe PJ et al. | β | 2012 | β |
| A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants. | Tao S et al. | β | 2012 | β |
| Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. | Bailey-Wilson JE et al. | β | 2012 | β |
| Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. | Kwon EM et al. | β | 2012 | β |
| A prioritization analysis of disease association by data-mining of functional annotation of human genes. | Taniya T et al. | β | 2012 | β |
| Are Toll-like receptor gene polymorphisms associated with prostate cancer? | Kutikhin AG et al. | β | 2012 | β |
| A robust method for testing association in genome-wide association studies. | Chen Z et al. | β | 2012 | β |
| A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases. | Tradonsky A et al. | β | 2012 | β |
| Assessing disease risk in genome-wide association studies using family history. | Ghosh A et al. | β | 2012 | β |
| Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy. | Valencia CA et al. | β | 2012 | β |
| Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men. | Nobata S et al. | β | 2012 | β |
| Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. | Zhu ML et al. | β | 2012 | β |
| Association between total number of deaths, diabetes mellitus, incident cancers, and haplotypes in chromosomal region 8q24 in a prospective study. | Guarrera S et al. | β | 2012 | β |
| Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population. | Joung JY et al. | β | 2012 | β |
| Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses. | Lu Y et al. | β | 2012 | β |
| A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. | Gudmundsson J et al. | β | 2012 | β |
| A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. | Bhattacharjee S et al. | β | 2012 | β |
| Cancer. The utility of mouse models in post-GWAS research. | Lewis A et al. | β | 2012 | β |
| Characterization of gene-environment interactions for colorectal cancer susceptibility loci. | Hutter CM et al. | β | 2012 | β |
| Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. | Tuupanen S et al. | β | 2012 | β |
| Cohesin is required for activation of MYC by estradiol. | McEwan MV et al. | β | 2012 | β |
| Common genetic variants in miR-1206 (8q24.2) and miR-612 (11q13.3) affect biogenesis of mature miRNA forms. | Kim HK et al. | β | 2012 | β |
| Common genetic variants in the 8q24 region and risk of papillary thyroid cancer. | Neta G et al. | β | 2012 | β |
| Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. | Postel-Vinay S et al. | β | 2012 | β |
| Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. | Chung CC et al. | β | 2012 | β |
| Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer. | Breyer JP et al. | β | 2012 | β |
| delGA (rs67491583) variant and colorectal cancer risk in an indigenous African population. | Ogundiran T et al. | β | 2012 | β |
| Early onset prostate cancer has a significant genetic component. | Lange EM et al. | β | 2012 | β |
| Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience. | Peppercorn J et al. | β | 2012 | β |
| Evaluating genetic risk for prostate cancer among Japanese and Latinos. | Cheng I et al. | β | 2012 | β |
| Evaluation of allele-specific somatic changes of genome-wide association study susceptibility alleles in human colorectal cancers. | Gerber MM et al. | β | 2012 | β |
| Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. | Grisanzio C et al. | β | 2012 | β |
| Genetic association of the KLK4 locus with risk of prostate cancer. | Lose F et al. | β | 2012 | β |
| Genetic variants associated with predisposition to prostate cancer and potential clinical implications. | Goh CL et al. | β | 2012 | β |
| Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. | Jin G et al. | β | 2012 | β |
| Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy. | Huang SP et al. | β | 2012 | β |
| Gene variants in the angiogenesis pathway and prostate cancer. | Amankwah EK et al. | β | 2012 | β |
| Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. | Xu J et al. | β | 2012 | β |
| Genome-wide association study of glioma and meta-analysis. | Rajaraman P et al. | β | 2012 | β |
| Genome-wide two-locus epistasis scans in prostate cancer using two European populations. | Tao S et al. | β | 2012 | β |
| Identification of putative cancer genes through data integration and comparative genomics between plants and humans. | Quimbaya M et al. | β | 2012 | β |
| Identifying genetic marker sets associated with phenotypes via an efficient adaptive score test. | Cai T et al. | β | 2012 | β |
| Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer. | Jia P et al. | β | 2012 | β |
| Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. | Lavender NA et al. | β | 2012 | β |
| Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. | Tsilidis KK et al. | β | 2012 | β |
| Invited commentary: more surprises from a gene desert. | Wacholder S et al. | β | 2012 | β |
| IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. | Nguyen HH et al. | β | 2012 | β |
| Meta-analysis of new genome-wide association studies of colorectal cancer risk. | Peters U et al. | β | 2012 | β |
| Oncogenomics methods and resources. | Furney SJ et al. | β | 2012 | β |
| Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations. | Zhu ML et al. | β | 2012 | β |
| Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. | Li S et al. | β | 2012 | β |
| Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population. | Gaj P et al. | β | 2012 | β |
| Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial. | Kader AK et al. | β | 2012 | β |
| Power of a reproducing kernel-based method for testing the joint effect of a set of single-nucleotide polymorphisms. | He H et al. | β | 2012 | β |
| Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs. | Zheng J et al. | β | 2012 | β |
| Prostate cancer genomics, biology, and risk assessment through genome-wide association studies. | Nakagawa H et al. | β | 2012 | β |
| Prostate cancer: germline prediction for a commonly variable malignancy. | Bambury RM et al. | β | 2012 | β |
| [Prostate cancer: promising biomarkers related to aggressive disease]. | Ribeiro da Silva MN et al. | β | 2012 | β |
| Prostate cancer risk variants are not associated with disease progression. | Szulkin R et al. | β | 2012 | β |
| Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis. | Troutman SM et al. | β | 2012 | β |
| Regulators of gene expression as biomarkers for prostate cancer. | Willard SS et al. | β | 2012 | β |
| Risk loci on chromosome 8q24 are associated with prostate cancer in northern Chinese men. | Liu M et al. | β | 2012 | β |
| Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy. | Bao BY et al. | β | 2012 | β |
| Suggestive evidence of linkage identified at chromosomes 12q24 and 2p16 in African American prostate cancer families from Louisiana. | Ledet EM et al. | β | 2012 | β |
| Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. | Theodoratou E et al. | β | 2012 | β |
| Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. | Mocellin S et al. | β | 2012 | β |
| The 8q24 gene desert: an oasis of non-coding transcriptional activity. | Huppi K et al. | β | 2012 | β |
| The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. | Meyer TE et al. | β | 2012 | β |
| The complexity of prostate cancer: genomic alterations and heterogeneity. | Boyd LK et al. | β | 2012 | β |
| The influence of race and ethnicity on the biology of cancer. | Henderson BE et al. | β | 2012 | β |
| The role of BRCA1 and BRCA2 in prostate cancer. | Castro E et al. | β | 2012 | β |
| The role of genetic markers in the management of prostate cancer. | Choudhury AD et al. | β | 2012 | β |
| The TERT variant rs2736100 is associated with colorectal cancer risk. | Kinnersley B et al. | β | 2012 | β |
| TRM: a powerful two-stage machine learning approach for identifying SNP-SNP interactions. | Lin HY et al. | β | 2012 | β |
| Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease. | Bademci G et al. | β | 2012 | β |
| Using graded response model for the prediction of prostate cancer risk. | Chen SH et al. | β | 2012 | β |
| Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). | Jin G et al. | β | 2012 | β |
| Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. | Wang Z et al. | β | 2012 | β |
| A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13. | Feng J et al. | β | 2011 | β |
| Allergy and glioma risk: test of association by genotype. | Dobbins SE et al. | β | 2011 | β |
| A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. | Gong C et al. | β | 2011 | β |
| A new association test based on Chi-square partition for case-control GWA studies. | Chen Z | β | 2011 | β |
| A powerful hybrid approach to select top single-nucleotide polymorphisms for genome-wide association study. | Wang J et al. | β | 2011 | β |
| Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. | Ciampa J et al. | β | 2011 | β |
| A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population. | Batra J et al. | β | 2011 | β |
| A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population. | Liu M et al. | β | 2011 | β |
| Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data. | Batra J et al. | β | 2011 | β |
| Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population. | Zhou CH et al. | β | 2011 | β |
| Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. | Chung S et al. | β | 2011 | β |
| Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. | Penney KL et al. | β | 2011 | β |
| Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. | Kutikhin AG | β | 2011 | β |
| Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. | Pomerantz MM et al. | β | 2011 | β |
| Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population. | Suzuki M et al. | β | 2011 | β |
| A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies. | Ishak MB et al. | β | 2011 | β |
| BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data. | Fachal L et al. | β | 2011 | β |
| Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. | Lindstrom S et al. | β | 2011 | β |
| Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. | Haiman CA et al. | β | 2011 | β |
| Chromosome 7p11.2 (EGFR) variation influences glioma risk. | Sanson M et al. | β | 2011 | β |
| Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry. | Okobia MN et al. | β | 2011 | β |
| Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer. | Huang SP et al. | β | 2011 | β |
| Common variants of the thyroglobulin gene are associated with differentiated thyroid cancer risk. | Akdi A et al. | β | 2011 | β |
| Current status of genome-wide association studies in cancer. | Chung CC et al. | β | 2011 | β |
| Cytogenomic aberrations associated with prostate cancer. | Gu G et al. | β | 2011 | β |
| Early detection of prostate cancer with emphasis on genetic markers. | Aly M et al. | β | 2011 | β |
| Efficient p-value evaluation for resampling-based tests. | Yu K et al. | β | 2011 | β |
| Ethnic differences in prostate cancer. | Kheirandish P et al. | β | 2011 | β |
| Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. | Machiela MJ et al. | β | 2011 | β |
| Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study. | Wang Y et al. | β | 2011 | β |
| Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. | Chung CC et al. | β | 2011 | β |
| Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. | Chen F et al. | β | 2011 | β |
| Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35. | Liu X et al. | β | 2011 | β |
| Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. | Parikh H et al. | β | 2011 | β |
| Functional annotation of risk loci identified through genome-wide association studies for prostate cancer. | Lu Y et al. | β | 2011 | β |
| Genetic and epigenetic changes in human prostate cancer. | Koochekpour S | β | 2011 | β |
| Genetic architecture of prostate cancer in the Ashkenazi Jewish population. | Vijai J et al. | β | 2011 | β |
| Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variant. | Zeegers MP et al. | β | 2011 | β |
| Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. | Kwon EM et al. | β | 2011 | β |
| Genetic susceptibility to bladder cancer risk and outcome. | Gu J et al. | β | 2011 | β |
| Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. | Becker F et al. | β | 2011 | β |
| Genome-wide association studies for detecting cancer susceptibility. | Hosking FJ et al. | β | 2011 | β |
| Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. | FitzGerald LM et al. | β | 2011 | β |
| Genome-wide association study identifies new prostate cancer susceptibility loci. | Schumacher FR et al. | β | 2011 | β |
| Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. | Haiman CA et al. | β | 2011 | β |
| Genome-wide association study of relative telomere length. | Prescott J et al. | β | 2011 | β |
| Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. | Purdue MP et al. | β | 2011 | β |
| Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer. | Jin G et al. | β | 2011 | β |
| Genotype-environment interactions and their translational implications. | Baye TM et al. | β | 2011 | β |
| Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility. | Xie CC et al. | β | 2011 | β |
| GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). | Xu Z et al. | β | 2011 | β |
| Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk. | Joung JY et al. | β | 2011 | β |
| Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. | Jin G et al. | β | 2011 | β |
| Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. | Gorlova O et al. | β | 2011 | β |
| Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective study. | Cornu JN et al. | β | 2011 | β |
| Including additional controls from public databases improves the power of a genome-wide association study. | Mukherjee S et al. | β | 2011 | β |
| Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. | Sun J et al. | β | 2011 | β |
| Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. | Ciampa J et al. | β | 2011 | β |
| Large-scale fine mapping of the HNF1B locus and prostate cancer risk. | Berndt SI et al. | β | 2011 | β |
| Mapping of disease-associated variants in admixed populations. | Shriner D et al. | β | 2011 | β |
| Mapping QTLs for improving grain yield using the USDA rice mini-core collection. | Li X et al. | β | 2011 | β |
| Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. | Brisbin AG et al. | β | 2011 | β |
| Meta-analysis of genome-wide and replication association studies on prostate cancer. | Liu H et al. | β | 2011 | β |
| Most lung and colon cancer susceptibility genes are pair-wise linked in mice, humans and rats. | Quan L et al. | β | 2011 | β |
| Multiple loci are associated with white blood cell phenotypes. | Nalls MA et al. | β | 2011 | β |
| Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders. | Glinskii AB et al. | β | 2011 | β |
| New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. | Nam RK et al. | β | 2011 | β |
| Novel genetic loci associated with prostate cancer in the Japanese population. | Sun Y et al. | β | 2011 | β |
| Novel rank-based approaches for discovery and replication in genome-wide association studies. | Kuo CL et al. | β | 2011 | β |
| Planning a genome-wide association study: points to consider. | Hakonarson H et al. | β | 2011 | β |
| Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer. | Witte JS et al. | β | 2011 | β |
| Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. | Pashayan N et al. | β | 2011 | β |
| Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer. | Lochhead P et al. | β | 2011 | β |
| Progress and promise of genome-wide association studies for human complex trait genetics. | Stranger BE et al. | β | 2011 | β |
| Prostate cancer incidence rates in Africa. | Chu LW et al. | β | 2011 | β |
| Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. | Ahn J et al. | β | 2011 | β |
| Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. | Helfand BT et al. | β | 2011 | β |
| Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness. | Lin HY et al. | β | 2011 | β |
| [Recent progress in genetic variants associated with cancer and their implications in diagnostics development]. | Cho WC | β | 2011 | β |
| Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans. | Barnholtz-Sloan JS et al. | β | 2011 | β |
| Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province. | Jiang Y et al. | β | 2011 | β |
| Robust joint analysis allowing for model uncertainty in two-stage genetic association studies. | Pan D et al. | β | 2011 | β |
| Role of organic cation transporters in drug-induced toxicity. | Ciarimboli G | β | 2011 | β |
| Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. | Liu F et al. | β | 2011 | β |
| The evolving role of familial history for prostate cancer. | Colloca G et al. | β | 2011 | β |
| The genetics of cancer risk. | Pomerantz MM et al. | β | 2011 | β |
| The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease. | Papanikolopoulou A et al. | β | 2011 | β |
| The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context. | Berg CD | β | 2011 | β |
| Understanding the contribution of synonymous mutations to human disease. | Sauna ZE et al. | β | 2011 | β |
| Validation of genome-wide prostate cancer associations in men of African descent. | Chang BL et al. | β | 2011 | β |
| Within-group differences between native-born and foreign-born Black men on prostate cancer risk reduction and early detection practices. | Odedina FT et al. | β | 2011 | β |
| 8q24 allelic imbalance and MYC gene copy number in primary prostate cancer. | Chen H et al. | β | 2010 | β |
| A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. | Ioannidis JP et al. | β | 2010 | β |
| A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. | Schumacher FR et al. | β | 2010 | β |
| A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. | Parikh H et al. | β | 2010 | β |
| A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. | Andersson U et al. | β | 2010 | β |
| A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). | Enciso-Mora V et al. | β | 2010 | β |
| A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. | Newman AB et al. | β | 2010 | β |
| A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. | Rothman N et al. | β | 2010 | β |
| A partially linear tree-based regression model for multivariate outcomes. | Yu K et al. | β | 2010 | β |
| A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study). | Murad AS et al. | β | 2010 | β |
| Approaches for evaluating rare polymorphisms in genetic association studies. | Li Q et al. | β | 2010 | β |
| Architecture of inherited susceptibility to common cancer. | Fletcher O et al. | β | 2010 | β |
| Assessing sources of inconsistencies in genotypes and their effects on genome-wide association studies with HapMap samples. | Hong H et al. | β | 2010 | β |
| Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy. | Huang SP et al. | β | 2010 | β |
| Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. | Chu LW et al. | β | 2010 | β |
| Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. | Zheng SL et al. | β | 2010 | β |
| Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. | Lubahn J et al. | β | 2010 | β |
| Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. | Klein RJ et al. | β | 2010 | β |
| Cancer and inflammation: promise for biologic therapy. | Demaria S et al. | β | 2010 | β |
| Chromosome 8q24-Associated Cancers and MYC. | Grisanzio C et al. | β | 2010 | β |
| Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer. | Bao BY et al. | β | 2010 | β |
| Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. | Crowther-Swanepoel D et al. | β | 2010 | β |
| Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men. | Chen M et al. | β | 2010 | β |
| Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history. | Hsu FC et al. | β | 2010 | β |
| Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. | Canzian F et al. | β | 2010 | β |
| Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy. | Rebbeck TR et al. | β | 2010 | β |
| Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. | Zhong H et al. | β | 2010 | β |
| Designs for linkage analysis and association studies of complex diseases. | Cui Y et al. | β | 2010 | β |
| Efficiency robust statistics for genetic linkage and association studies under genetic model uncertainty. | Joo J et al. | β | 2010 | β |
| Estimation of genotype relative risks from pedigree data by retrospective likelihoods. | Schaid DJ et al. | β | 2010 | β |
| Evaluating variations of genotype calling: a potential source of spurious associations in genome-wide association studies. | Hong H et al. | β | 2010 | β |
| Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. | Elliott KS et al. | β | 2010 | β |
| Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus. | Johanneson B et al. | β | 2010 | β |
| Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk. | Helfand BT et al. | β | 2010 | β |
| Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization. | Schulze TG | β | 2010 | β |
| Genetic risk information for common diseases may indeed be already useful for prevention and early detection. | Gulcher J et al. | β | 2010 | β |
| Genetics of prostate cancer risk. | Pomerantz MM et al. | β | 2010 | β |
| Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. | Pierce BL et al. | β | 2010 | β |
| Genetic variation and risk of chronic lymphocytic leukaemia. | Crowther-Swanepoel D et al. | β | 2010 | β |
| Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. | Mirabello L et al. | β | 2010 | β |
| Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. | Setlur SR et al. | β | 2010 | β |
| Genitourinary cancer predisposition syndromes. | Gallagher DJ et al. | β | 2010 | β |
| Genome-wide association studies and beyond. | Witte JS | β | 2010 | β |
| Genome-wide association studies in cancer--current and future directions. | Chung CC et al. | β | 2010 | β |
| Genome-wide association studies in common cancers--what have we learnt? | Varghese JS et al. | β | 2010 | β |
| Genome-wide association studies of cancer. | Stadler ZK et al. | β | 2010 | β |
| Genome-wide association studies of cancer predisposition. | Stadler ZK et al. | β | 2010 | β |
| Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. | Takata R et al. | β | 2010 | β |
| Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. | Petukhova L et al. | β | 2010 | β |
| Genome-wide association study of prostate cancer mortality. | Penney KL et al. | β | 2010 | β |
| Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. | Radstake TR et al. | β | 2010 | β |
| Germline variation controls the architecture of somatic alterations in tumors. | Dworkin AM et al. | β | 2010 | β |
| Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. | Noushmehr H et al. | β | 2010 | β |
| Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease. | Bao BY et al. | β | 2010 | β |
| Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. | Xu J et al. | β | 2010 | β |
| Inherited variation in immune genes and pathways and glioblastoma risk. | Schwartzbaum JA et al. | β | 2010 | β |
| In vivo exploration of the functional activity of the non-coding 8q24 prostate cancer risk locus. | Lamb DJ et al. | β | 2010 | β |
| Long-range enhancers on 8q24 regulate c-Myc. | Sotelo J et al. | β | 2010 | β |
| Low-penetrance susceptibility to hematological malignancy. | Houlston RS | β | 2010 | β |
| Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients. | Hemminki K et al. | β | 2010 | β |
| Molecular genetics of prostate cancer: new prospects for old challenges. | Shen MM et al. | β | 2010 | β |
| MYC and Prostate Cancer. | Koh CM et al. | β | 2010 | β |
| New insights into susceptibility to glioma. | Liu Y et al. | β | 2010 | β |
| Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. | Roukos DH | β | 2010 | β |
| Number of prostate cancer risk alleles may identify possibly 'insignificant' disease. | Helfand BT et al. | β | 2010 | β |
| Personalized medicine: marking a new epoch in cancer patient management. | Diamandis M et al. | β | 2010 | β |
| Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer. | Koutros S et al. | β | 2010 | β |
| Powerful SNP-set analysis for case-control genome-wide association studies. | Wu MC et al. | β | 2010 | β |
| Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers? | Wiklund F | β | 2010 | β |
| Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. | Whitman EJ et al. | β | 2010 | β |
| Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation. | Kim ST et al. | β | 2010 | β |
| Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies. | MacInnis RJ et al. | β | 2010 | β |
| Recent progress in genetic variants associated with cancer and their implications in diagnostics development. | Cho WC | β | 2010 | β |
| Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. | Prokunina-Olsson L et al. | β | 2010 | β |
| Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. | Riley B et al. | β | 2010 | β |
| Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. | Hooker S et al. | β | 2010 | β |
| Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations. | Enciso-Mora V et al. | β | 2010 | β |
| Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T] in multiple racial/ethnic groups: results from the Los Angeles-Shanghai case-control study. | Cortessis VK et al. | β | 2010 | β |
| Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. | Chen L et al. | β | 2010 | β |
| Search for cancer risk factors with microarray-based genome-wide association studies. | Zhang L et al. | β | 2010 | β |
| Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. | LindstrΓΆm S et al. | β | 2010 | β |
| Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. | Beuten J et al. | β | 2010 | β |
| Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. | Kloss-BrandstΓ€tter A et al. | β | 2010 | β |
| Susceptibility loci associated with prostate cancer progression and mortality. | Gallagher DJ et al. | β | 2010 | β |
| The association of telomere length and genetic variation in telomere biology genes. | Mirabello L et al. | β | 2010 | β |
| The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. | Cornelis MC et al. | β | 2010 | β |
| The pursuit of genome-wide association studies: where are we now? | Ku CS et al. | β | 2010 | β |
| The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. | WokoΕorczyk D et al. | β | 2010 | β |
| Two-stage testing strategies for genome-wide association studies in family-based designs. | Murphy A et al. | β | 2010 | β |
| Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression. | Zhao H et al. | β | 2010 | β |
| Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. | White KL et al. | β | 2010 | β |
| What are genome-wide association studies telling us about B-cell tumor development? | Sherborne AL et al. | β | 2010 | β |
| Adipokine genes and prostate cancer risk. | Moore SC et al. | β | 2009 | β |
| A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. | Vineis P et al. | β | 2009 | β |
| A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. | Song H et al. | β | 2009 | β |
| A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. | Landi MT et al. | β | 2009 | β |
| A genome-wide association study primer for clinicians. | Wang TH et al. | β | 2009 | β |
| Analysis of Case-Control Association Studies: SNPs, Imputation and Haplotypes. | Chatterjee N et al. | β | 2009 | β |
| Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. | Fitzgerald LM et al. | β | 2009 | β |
| A neurologist's guide to genome-wide association studies. | Mullen SA et al. | β | 2009 | β |
| A novel prostate cancer susceptibility locus at 19q13. | Hsu FC et al. | β | 2009 | β |
| A pilot genome-wide association study of early-onset breast cancer. | Kibriya MG et al. | β | 2009 | β |
| Application of imputation methods to the analysis of rheumatoid arthritis data in genome-wide association studies. | Childers DK et al. | β | 2009 | β |
| Association between an 8q24 locus and the risk of colorectal cancer in Japanese. | Matsuo K et al. | β | 2009 | β |
| Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. | Quaye L et al. | β | 2009 | β |
| Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. | Meyer A et al. | β | 2009 | β |
| Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. | Beuten J et al. | β | 2009 | β |
| Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. | Collin SM et al. | β | 2009 | β |
| Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. | Wiklund F et al. | β | 2009 | β |
| Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. | Agalliu I et al. | β | 2009 | β |
| A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. | ChiΓ² A et al. | β | 2009 | β |
| Beyond odds ratios--communicating disease risk based on genetic profiles. | Kraft P et al. | β | 2009 | β |
| Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. | Salinas CA et al. | β | 2009 | β |
| Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry. | Pal P et al. | β | 2009 | β |
| Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. | Yeager M et al. | β | 2009 | β |
| Control selection options for genome-wide association studies in cohorts. | Wacholder S et al. | β | 2009 | β |
| CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. | Travis RC et al. | β | 2009 | β |
| Data modeling as a main source of discrepancies in single and multiple marker association methods. | Ledur MC et al. | β | 2009 | β |
| Enrichment of sequencing targets from the human genome by solution hybridization. | Tewhey R et al. | β | 2009 | β |
| Established prostate cancer susceptibility variants are not associated with disease outcome. | Wiklund FE et al. | β | 2009 | β |
| Estimation of absolute risk for prostate cancer using genetic markers and family history. | Xu J et al. | β | 2009 | β |
| Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. | Penney KL et al. | β | 2009 | β |
| Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. | Lou H et al. | β | 2009 | β |
| Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. | Chang BL et al. | β | 2009 | β |
| Functional and clinical significance of variants localized to 8q24 in colon cancer. | Cicek MS et al. | β | 2009 | β |
| Genetic background comparison using distance-based regression, with applications in population stratification evaluation and adjustment. | Li Q et al. | β | 2009 | β |
| Genetic polymorphisms and early-onset prostate cancer: a real potential to personalize prostate cancer screening? | Hughes L et al. | β | 2009 | β |
| Genetic prognostic and predictive markers in colorectal cancer. | Walther A et al. | β | 2009 | β |
| Genetics and the general physician: insights, applications and future challenges. | Knight JC | β | 2009 | β |
| Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. | Zheng SL et al. | β | 2009 | β |
| Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes. | Breyer JP et al. | β | 2009 | β |
| Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. | Wu X et al. | β | 2009 | β |
| Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. | Chen M et al. | β | 2009 | β |
| Genome-wide and candidate gene association study of cigarette smoking behaviors. | Caporaso N et al. | β | 2009 | β |
| Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. | Gudmundsson J et al. | β | 2009 | β |
| Genome-wide association studies and the genetic dissection of complex traits. | Sebastiani P et al. | β | 2009 | β |
| Genome-wide association studies--a summary for the clinical gastroenterologist. | Melum E et al. | β | 2009 | β |
| Genome-wide association studies in type 1 diabetes, inflammatory bowel disease and other immune-mediated disorders. | Hakonarson H et al. | β | 2009 | β |
| Genome-wide association study identifies five susceptibility loci for glioma. | Shete S et al. | β | 2009 | β |
| Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. | Knight JA et al. | β | 2009 | β |
| Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. | Chen M et al. | β | 2009 | β |
| Genomic approaches to outcome prediction in prostate cancer. | Febbo PG | β | 2009 | β |
| Genomic regulatory blocks in vertebrates and implications in human disease. | Navratilova P et al. | β | 2009 | β |
| Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. | TreviΓ±o LR et al. | β | 2009 | β |
| Human genetic variations: Beacons on the pathways to successful ageing. | Cluett C et al. | β | 2009 | β |
| Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter. | Hagedorn C et al. | β | 2009 | β |
| Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. | FitzGerald LM et al. | β | 2009 | β |
| Identification of new genetic risk factors for prostate cancer. | Guy M et al. | β | 2009 | β |
| Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. | Eeles RA et al. | β | 2009 | β |
| Implications of chimaeric non-co-linear transcripts. | Gingeras TR | β | 2009 | β |
| Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. | Kader AK et al. | β | 2009 | β |
| Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. | Jakobsdottir J et al. | β | 2009 | β |
| Joint analysis of tightly linked SNPs in screening step of genome-wide association studies leads to increased power. | Becker T et al. | β | 2009 | β |
| Location, location, (ChIP-)location! Mapping chromatin landscapes one immunoprecipitation at a time. | Berman BP et al. | β | 2009 | β |
| Low penetrance breast cancer predisposition SNPs are site specific. | Mcinerney N et al. | β | 2009 | β |
| Molecular biomarkers in prostate cancer. | MartΓnez CH et al. | β | 2009 | β |
| Molecular epidemiology of DNA repair genes in bladder cancer. | Kiltie AE | β | 2009 | β |
| Molecular epidemiology of primary brain tumors. | Gu J et al. | β | 2009 | β |
| Multiple loci on 8q24 associated with prostate cancer susceptibility. | Al Olama AA et al. | β | 2009 | β |
| Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese. | Huang QY et al. | β | 2009 | β |
| Nitric oxide synthase gene polymorphisms and prostate cancer risk. | Lee KM et al. | β | 2009 | β |
| Nonmetric multidimensional scaling corrects for population structure in association mapping with different sample types. | Zhu C et al. | β | 2009 | β |
| On quality control measures in genome-wide association studies: a test to assess the genotyping quality of individual probands in family-based association studies and an application to the HapMap data. | Fardo DW et al. | β | 2009 | β |
| Parallel routes of human carcinoma development: implications of the age-specific incidence data. | Brody JP | β | 2009 | β |
| Pathological outcomes associated with the 17q prostate cancer risk variants. | Helfand BT et al. | β | 2009 | β |
| Pathway analysis by adaptive combination of P-values. | Yu K et al. | β | 2009 | β |
| Polygenic susceptibility to breast cancer: current state-of-the-art. | Ghoussaini M et al. | β | 2009 | β |
| Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. | Gourh P et al. | β | 2009 | β |
| Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. | Chang MH et al. | β | 2009 | β |
| Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy. | Huang SP et al. | β | 2009 | β |
| Prostate cancer genomics: towards a new understanding. | Witte JS | β | 2009 | β |
| Prostate cancer risk associated loci in African Americans. | Xu J et al. | β | 2009 | β |
| Recovering unused information in genome-wide association studies: the benefit of analyzing SNPs out of Hardy-Weinberg equilibrium. | Fardo DW et al. | β | 2009 | β |
| Replication of prostate cancer risk loci in a Japanese case-control association study. | Yamada H et al. | β | 2009 | β |
| Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study. | Camp NJ et al. | β | 2009 | β |
| Results from a prostate cancer admixture mapping study in African-American men. | Bock CH et al. | β | 2009 | β |
| Robust tests for single-marker analysis in case-control genetic association studies. | Li Q et al. | β | 2009 | β |
| Sequence variants at 22q13 are associated with prostate cancer risk. | Sun J et al. | β | 2009 | β |
| Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. | Rafnar T et al. | β | 2009 | β |
| Shrinkage estimation for robust and efficient screening of single-SNP association from case-control genome-wide association studies. | Luo S et al. | β | 2009 | β |
| Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men. | Liu M et al. | β | 2009 | β |
| SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. | Xu Z et al. | β | 2009 | β |
| Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. | Wang L et al. | β | 2009 | β |
| Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. | Little J et al. | β | 2009 | β |
| Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. | Little J et al. | β | 2009 | β |
| Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. | Little J et al. | β | 2009 | β |
| STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. | Little J et al. | β | 2009 | β |
| STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. | Little J et al. | β | 2009 | β |
| STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. | Little J et al. | β | 2009 | β |
| STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. | Little J et al. | β | 2009 | β |
| Surveying germline genomic landscape of breast cancer. | Hemminki K et al. | β | 2009 | β |
| Systematic haplotype analysis resolves a complex plasma plant sterol locus on the Micronesian Island of Kosrae. | Kenny EE et al. | β | 2009 | β |
| Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition. | Zhou P et al. | β | 2009 | β |
| The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. | Pomerantz MM et al. | β | 2009 | β |
| The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. | Mirabello L et al. | β | 2009 | β |
| The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. | Tuupanen S et al. | β | 2009 | β |
| The HapMap and genome-wide association studies in diagnosis and therapy. | Manolio TA et al. | β | 2009 | β |
| The inherited genetic component of sporadic pancreatic adenocarcinoma. | Milne RL et al. | β | 2009 | β |
| The rs1447295 at 8q24 is a risk variant for prostate cancer in Taiwanese men. | Chen M et al. | β | 2009 | β |
| Two independent prostate cancer risk-associated Loci at 11q13. | Zheng SL et al. | β | 2009 | β |
| Use of SNPs in cancer predisposition analysis, diagnosis and prognosis: tools and prospects. | Boyd LK et al. | β | 2009 | β |
| Utility of incorporating genetic variants for the early detection of prostate cancer. | Nam RK et al. | β | 2009 | β |
| Validating, augmenting and refining genome-wide association signals. | Ioannidis JP et al. | β | 2009 | β |
| VALID: visualization of association study results and linkage disequilibrium. | Jorgenson E et al. | β | 2009 | β |
| Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. | Ahn J et al. | β | 2009 | β |
| Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. | Koutros S et al. | β | 2009 | β |
| 8q24 and prostate cancer: association with advanced disease and meta-analysis. | Cheng I et al. | β | 2008 | β |
| A common 8q24 variant and the risk of colon cancer: a population-based case-control study. | Li L et al. | β | 2008 | β |
| A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. | Nam RK et al. | β | 2008 | β |
| A HapMap harvest of insights into the genetics of common disease. | Manolio TA et al. | β | 2008 | β |
| Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. | Tuupanen S et al. | β | 2008 | β |
| Androgen and prostate cancer: is the hypothesis dead? | Hsing AW et al. | β | 2008 | β |
| Androgens and the molecular epidemiology of prostate cancer. | Chu LW et al. | β | 2008 | β |
| A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. | Tavendale R et al. | β | 2008 | β |
| A range of cancers is associated with the rs6983267 marker on chromosome 8. | Wokolorczyk D et al. | β | 2008 | β |
| Array-based DNA diagnostics: let the revolution begin. | Beaudet AL et al. | β | 2008 | β |
| ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. | Lin D et al. | β | 2008 | β |
| Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples. | Hong H et al. | β | 2008 | β |
| Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. | Lango H et al. | β | 2008 | β |
| Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. | Sun J et al. | β | 2008 | β |
| Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population. | Terada N et al. | β | 2008 | β |
| Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. | Xu J et al. | β | 2008 | β |
| Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. | Park SL et al. | β | 2008 | β |
| Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. | Song H et al. | β | 2008 | β |
| A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. | Nakagawa T et al. | β | 2008 | β |
| A weighted-Holm procedure accounting for allele frequencies in genomewide association studies. | Dalmasso C et al. | β | 2008 | β |
| Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes. | Bonifaci N et al. | β | 2008 | β |
| Cancer genetic association studies in the genome-wide age. | Savage SA | β | 2008 | β |
| Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. | Levin AM et al. | β | 2008 | β |
| Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. | Beebe-Dimmer JL et al. | β | 2008 | β |
| Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients. | Sun J et al. | β | 2008 | β |
| Collapsing SNP genotypes in case-control genome-wide association studies increases the type I error rate and power. | Matthews AG et al. | β | 2008 | β |
| Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. | Tan YC et al. | β | 2008 | β |
| Common and rare variants in multifactorial susceptibility to common diseases. | Bodmer W et al. | β | 2008 | β |
| Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. | Jaeger E et al. | β | 2008 | β |
| Common genetic variation and human disease. | Orr N et al. | β | 2008 | β |
| Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. | Gudmundsson J et al. | β | 2008 | β |
| Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. | Yeager M et al. | β | 2008 | β |
| Cumulative association of five genetic variants with prostate cancer. | Zheng SL et al. | β | 2008 | β |
| Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. | Sun J et al. | β | 2008 | β |
| Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. | Meletiadis J et al. | β | 2008 | β |
| Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery. | Hutcheson HB et al. | β | 2008 | β |
| Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. | Cussenot O et al. | β | 2008 | β |
| Efficient approximation of P-value of the maximum of correlated tests, with applications to genome-wide association studies. | Li Q et al. | β | 2008 | β |
| Etiologic impact of known cancer susceptibility genes. | Hemminki K et al. | β | 2008 | β |
| Evaluating cost efficiency of SNP chips in genome-wide association studies. | Li C et al. | β | 2008 | β |
| Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. | Sun J et al. | β | 2008 | β |
| Expectations and challenges stemming from genome-wide association studies. | Vineis P et al. | β | 2008 | β |
| Family-based samples can play an important role in genetic association studies. | Lange EM et al. | β | 2008 | β |
| Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. | Ahn J et al. | β | 2008 | β |
| From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. | Nebert DW et al. | β | 2008 | β |
| Fusion in the ETS gene family and prostate cancer. | Narod SA et al. | β | 2008 | β |
| Gene-centric genomewide association study via entropy. | Cui Y et al. | β | 2008 | β |
| Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. | SolΓ© X et al. | β | 2008 | β |
| Genetic association analysis: a primer on how it works, its strengths and its weaknesses. | Rodriguez-Murillo L et al. | β | 2008 | β |
| Genetic determinants of phenotypic diversity in humans. | Rahim NG et al. | β | 2008 | β |
| Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. | Sirugo G et al. | β | 2008 | β |
| Genetic susceptibility loci for breast cancer by estrogen receptor status. | Garcia-Closas M et al. | β | 2008 | β |
| Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. | Dong LM et al. | β | 2008 | β |
| Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes. | Zeigler-Johnson CM et al. | β | 2008 | β |
| Genetic variants in the 8q24 locus and risk of testicular germ cell tumors. | Cook MB et al. | β | 2008 | β |
| Genetic variation in CYP17 and endometrial cancer risk. | Gaudet MM et al. | β | 2008 | β |
| Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. | Stevens VL et al. | β | 2008 | β |
| Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. | Lasky-Su J et al. | β | 2008 | β |
| Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. | Liu YJ et al. | β | 2008 | β |
| Genome-wide association studies for complex traits: consensus, uncertainty and challenges. | McCarthy MI et al. | β | 2008 | β |
| Genome-wide association studies in cancer. | Easton DF et al. | β | 2008 | β |
| Genome-wide association studies: progress and potential for drug discovery and development. | Kingsmore SF et al. | β | 2008 | β |
| Genome-wide screen for asthma in Puerto Ricans: evidence for association with 5q23 region. | Choudhry S et al. | β | 2008 | β |
| Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. | Garcia-Closas M et al. | β | 2008 | β |
| Hyaluronan and hyaluronidase in genitourinary tumors. | Simpson MA et al. | β | 2008 | β |
| Identification of ten loci associated with height highlights new biological pathways in human growth. | Lettre G et al. | β | 2008 | β |
| Identifying host targets for drug development with knowledge from genome-wide studies: lessons from HIV-AIDS. | Winkler CA | β | 2008 | β |
| Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. | Li Q et al. | β | 2008 | β |
| Inherited predisposition to chronic lymphocytic leukemia. | Brown JR | β | 2008 | β |
| Lack of a relationship between the common 8q24 variant rs6983267 and risk of chronic lymphocytic leukemia. | Sellick GS et al. | β | 2008 | β |
| Linkage and association: basic concepts. | Borecki IB et al. | β | 2008 | β |
| Lung cancer epigenetics and genetics. | Risch A et al. | β | 2008 | β |
| MAX-rank: a simple and robust genome-wide scan for case-control association studies. | Li Q et al. | β | 2008 | β |
| Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. | COGENT Study et al. | β | 2008 | β |
| Microarray technology and applications in the arena of genome-wide association. | Grant SF et al. | β | 2008 | β |
| Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets. | Gurel B et al. | β | 2008 | β |
| Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. | Salinas CA et al. | β | 2008 | β |
| Multiple loci identified in a genome-wide association study of prostate cancer. | Thomas G et al. | β | 2008 | β |
| Multiple loci with different cancer specificities within the 8q24 gene desert. | Ghoussaini M et al. | β | 2008 | β |
| Multiple newly identified loci associated with prostate cancer susceptibility. | Eeles RA et al. | β | 2008 | β |
| MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. | Kopp JB et al. | β | 2008 | β |
| New cancer susceptibility loci: population and familial risks. | Hemminki K et al. | β | 2008 | β |
| PGA: power calculator for case-control genetic association analyses. | Menashe I et al. | β | 2008 | β |
| Polymorphisms in mitochondrial genes and prostate cancer risk. | Wang L et al. | β | 2008 | β |
| Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. | Berndt SI et al. | β | 2008 | β |
| Population differences in breast cancer severity. | Fejerman L et al. | β | 2008 | β |
| Population substructure and control selection in genome-wide association studies. | Yu K et al. | β | 2008 | β |
| Predicting unobserved phenotypes for complex traits from whole-genome SNP data. | Lee SH et al. | β | 2008 | β |
| Profiling the expression pattern of GPI transamidase complex subunits in human cancer. | Nagpal JK et al. | β | 2008 | β |
| Prostatic preneoplasia and beyond. | Joshua AM et al. | β | 2008 | β |
| Re: Cumulative association of five genetic variants with prostate cancer. | Gleave M | β | 2008 | β |
| Selenium and the prevention of prostate and colorectal cancer. | Peters U et al. | β | 2008 | β |
| Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. | Kiemeney LA et al. | β | 2008 | β |
| Serum vitamin D concentration and prostate cancer risk: a nested case-control study. | Ahn J et al. | β | 2008 | β |
| Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. | Ding Y et al. | β | 2008 | β |
| Study designs for genome-wide association studies. | Kraft P et al. | β | 2008 | β |
| The complex genetics of multiple sclerosis: pitfalls and prospects. | Sawcer S | β | 2008 | β |
| The emerging landscape of breast cancer susceptibility. | Stratton MR et al. | β | 2008 | β |
| The future of mouse QTL mapping to diagnose disease in mice in the age of whole-genome association studies. | Hunter KW et al. | β | 2008 | β |
| The positives, protocols, and perils of genome-wide association. | Neale BM et al. | β | 2008 | β |
| The role of genetic variation in Toll-like receptor 4 in prostate cancer susceptibility: a review. | Cheng I et al. | β | 2008 | β |
| The search for genes contributing to endometriosis risk. | Montgomery GW et al. | β | 2008 | β |
| The success of the genome-wide association approach: a brief story of a long struggle. | Seng KC et al. | β | 2008 | β |
| TNF polymorphisms and prostate cancer risk. | Danforth KN et al. | β | 2008 | β |
| Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles. | Helfand BT et al. | β | 2008 | β |
| Tumor immunobiological differences in prostate cancer between African-American and European-American men. | Wallace TA et al. | β | 2008 | β |
| Variants in circadian genes and prostate cancer risk: a population-based study in China. | Chu LW et al. | β | 2008 | β |
| Visible Genotype Sensor Array. | Michikawa Y et al. | β | 2008 | β |
| What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? | Lango H et al. | β | 2008 | β |
| Y chromosome haplotypes and prostate cancer in Sweden. | LindstrΓΆm S et al. | β | 2008 | β |
| A common genetic risk factor for colorectal and prostate cancer. | Haiman CA et al. | β | 2007 | β |
| A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. | Tomlinson I et al. | β | 2007 | β |
| A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. | Murabito JM et al. | β | 2007 | β |
| A genotype calling algorithm for the Illumina BeadArray platform. | Teo YY et al. | β | 2007 | β |
| Biomarkers for diet and cancer prevention research: potentials and challenges. | Davis CD et al. | β | 2007 | β |
| Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. | Cussenot O et al. | β | 2007 | β |
| Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. | Robbins C et al. | β | 2007 | β |
| Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications. | Hahn NM et al. | β | 2007 | β |
| Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. | Estivill X et al. | β | 2007 | β |
| Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours. | Goldin LR et al. | β | 2007 | β |
| Fine mapping versus replication in whole-genome association studies. | Clarke GM et al. | β | 2007 | β |
| Future use of genomics in coronary artery disease. | Damani SB et al. | β | 2007 | β |
| Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. | Zanke BW et al. | β | 2007 | β |
| Genome-wide association studies of cancer. | Jorgenson E et al. | β | 2007 | β |
| Genome-wide association studies: progress in identifying genetic biomarkers in common, complex diseases. | Kingsmore SF et al. | β | 2007 | β |
| Genome-wide association study identifies novel breast cancer susceptibility loci. | Easton DF et al. | β | 2007 | β |
| Genomic biomarkers, androgen pathway and prostate cancer. | D'Amico F et al. | β | 2007 | β |
| Genomic signatures associated with the development, progression, and outcome of prostate cancer. | Mendiratta P et al. | β | 2007 | β |
| Hierarchical Bayes prioritization of marker associations from a genome-wide association scan for further investigation. | Lewinger JP et al. | β | 2007 | β |
| Interpreting P values in pharmacogenetic studies: a call for process and perspective. | Maitland ML et al. | β | 2007 | β |
| Multidrug resistance in epilepsy: a pharmacogenomic update. | Tate SK et al. | β | 2007 | β |
| Multiple prostate cancer risk variants on 8q24. | Witte JS | β | 2007 | β |
| New models of collaboration in genome-wide association studies: the Genetic Association Information Network. | GAIN Collaborative Research Group et al. | β | 2007 | β |
| New perspectives for the elucidation of genetic disorders. | Ropers HH | β | 2007 | β |
| PADB: published association database. | Rhee H et al. | β | 2007 | β |
| Power to detect risk alleles using genome-wide tag SNP panels. | Eberle MA et al. | β | 2007 | β |
| Replicating genotype-phenotype associations. | NCI-NHGRI Working Group on Replication in Association Studies et al. | β | 2007 | β |
| Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb. | Camp NJ et al. | β | 2007 | β |
| Studies of genes and cancer survival: pieces of the puzzle. | Wacholder S et al. | β | 2007 | β |
| Study designs to enhance identification of genetic factors in healthy aging. | Manolio TA | β | 2007 | β |
| The evidence for prostate cancer risk loci at 8q24 grows stronger. | Savage SA et al. | β | 2007 | β |
| Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. | Duggan D et al. | β | 2007 | β |
| Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. | Plenge RM et al. | β | 2007 | β |
| Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. | Gudmundsson J et al. | β | 2007 | β |
| Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery. | Keller MA et al. | β | 2007 | β |